norfloxacin has been researched along with Carcinoma, Anaplastic in 2 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bykowska, A | 1 |
| Komarnicka, UK | 1 |
| Jeżowska-Bojczuk, M | 1 |
| Kyzioł, A | 1 |
| Blondin, C | 1 |
| Costa, P | 1 |
| Bressolle, F | 1 |
| Navratil, H | 1 |
| Galtier, M | 1 |
2 other studies available for norfloxacin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Cu
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Apopt | 2018 |
Norfloxacin concentrations in plasma and human epididymal tissue after repeated oral administration.
Topics: Administration, Oral; Aged; Aged, 80 and over; Carcinoma; Epididymis; Humans; Male; Norfloxacin; Pro | 1991 |